JP Morgan Chase
AGTC

JP Morgan Chase’s Applied Genetic Technologies Corporation AGTC Stock Holding History

JP Morgan Chase’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-59,162
Closed -$300K – 6746
2021
Q1 		$300K Sell
59,162
-24,851
-30% -$129K ﹤0.01% 4969
2020
Q4 		$344K Buy
84,013
+74,942
+826% +$368K ﹤0.01% 4572
2020
Q3 		$45K Buy
9,071
+1,219
+16% +$6.66K ﹤0.01% 4974
2020
Q2 		$44K Buy
+7,852
New +$36K ﹤0.01% 4870
2020
Q1 		– Sell
-75,026
Closed -$339K – 5862
2019
Q4 		$339K Buy
75,026
+59,820
+393% +$189K ﹤0.01% 4442
2019
Q3 		$63K Buy
15,206
+506
+3% +$1.83K ﹤0.01% 5075
2019
Q2 		$55K Buy
14,700
+11,500
+359% +$47.1K ﹤0.01% 5134
2019
Q1 		$13K Sell
3,200
-2,945
-48% -$10.3K ﹤0.01% 5504
2018
Q4 		$15K Sell
6,145
-16,392
-73% -$96K ﹤0.01% 5377
2018
Q3 		$165K Buy
22,537
+6,967
+45% +$30.5K ﹤0.01% 4760
2018
Q2 		$58K Buy
+15,570
New +$72K ﹤0.01% 5031
2018
Q1 		– Sell
-920
Closed -$3K – 5708
2017
Q4 		$3K Buy
+920
New +$3.47K ﹤0.01% 5356
2017
Q3 		– Sell
-8,012
Closed -$41K – 5267
2017
Q2 		$41K Buy
+8,012
New +$45K ﹤0.01% 4391
2016
Q3 		– Sell
-150,798
Closed -$2.13M – 4905
2016
Q2 		$2.13M Sell
150,798
-12,791
-8% -$200K ﹤0.01% 2777
2016
Q1 		$2.29M Sell
163,589
-10,923
-6% -$160K ﹤0.01% 2631
2015
Q4 		$3.56M Sell
174,512
-24,688
-12% -$381K ﹤0.01% 2426
2015
Q3 		$2.62M Buy
199,200
+39,400
+25% +$654K ﹤0.01% 2611
2015
Q2 		$2.45M Sell
159,800
-9,325
-6% -$179K ﹤0.01% 2788
2015
Q1 		$3.38M Buy
169,125
+7,751
+5% +$173K ﹤0.01% 2594
2014
Q4 		$3.39M Sell
161,374
-23,964
-13% -$488K ﹤0.01% 2651
2014
Q3 		$3.45M Buy
185,338
+87,893
+90% +$1.59M ﹤0.01% 2597
2014
Q2 		$2.25M Buy
+97,445
New +$1.72M ﹤0.01% 2467

Other funds holding AGTC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

JP Morgan Chase's AGTC Position: Q2 2021 in Review

JP Morgan Chase sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 59,162 shares — an estimated $300K sold.

JP Morgan Chase first reported a position in AGTC in Q2 2014 and held it in 22 quarters. The position peaked at $3.56M in Q4 2015. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • JP Morgan Chase reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • JP Morgan Chase sold 59,162 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $300K.
  • JP Morgan Chase first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 22 quarters.
  • JP Morgan Chase's Applied Genetic Technologies Corporation position peaked at $3.56M in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.